Brandenburg Kapital portfolio firm 4TEEN4 wins FDA fast-track status for cardiogenic shock drug Invobenitug

Reuters2026/07/30 08:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Brandenburg Kapital portfolio company 4TEEN4 Pharmaceuticals secured U.S. FDA Fast Track designation for Invobenitug in cardiogenic shock.
Invobenitug is in a Phase Ib/IIa trial across several European countries.
Brandenburg Kapital has held an investment stake in 4TEEN4 since 2019.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brandenburg Kapital GmbH published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.

华尔街见闻•2026/09/12 04:41

AI infrastructure is too costly! Oracle adds $700 million to restructuring budget for layoff compensation

东方财富•2026/09/12 04:15